Literature DB >> 31514076

Risks of noncardiac surgery early after percutaneous coronary intervention.

Nathaniel R Smilowitz1, Jeffrey Lorin2, Jeffrey S Berger3.   

Abstract

BACKGROUND: Prior registry data suggest that 4%-20% of patients require noncardiac surgery (NCS) within 2 years of percutaneous coronary intervention (PCI). Contemporary data on NCS after PCI in the United States among women and men are limited. We determined the rate of early hospital readmission for NCS and associated outcomes in a large cohort of patients who underwent PCI in the United States.
METHODS: Adults undergoing PCI between January 1 and June 30, 2014, were identified from the Nationwide Readmission Database. Patients readmitted for NCS within 6 months of PCI were identified. Outcomes of interest were in-hospital death, myocardial infarction (MI), and bleeding defined by International Classification of Diseases, Ninth Revision, codes.
RESULTS: Among 221,379 patients who underwent PCI and survived to hospital discharge, 3.5% (n = 7,696) were readmitted for NCS within 6 months post-PCI, and 41% of these hospitalizations were elective. Early NCS was complicated by MI in 4.7% of cases, and 21% of perioperative MIs were fatal. Bleeding was recorded in 32.0% of patients. All-cause mortality occurred in 4.4% of patients (n = 339) readmitted for surgery. The risk of death or MI was greatest when NCS was performed within the first month after PCI.
CONCLUSIONS: Despite clear guidelines to avoid surgery early after PCI, NCS was performed in 1 of every 29 patients with recent PCI, corresponding to as many as ~30,000 patients each year nationwide. Surgical mortality and perioperative MI were high in this setting. Strategies to minimize perioperative thrombotic and bleeding risks during readmission for NCS after PCI are necessary. Published by Elsevier Inc.

Entities:  

Year:  2019        PMID: 31514076      PMCID: PMC6861674          DOI: 10.1016/j.ahj.2019.07.010

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  36 in total

1.  The incidence and timing of noncardiac surgery after cardiac stent implantation.

Authors:  Mary T Hawn; Laura A Graham; Joshua R Richman; Kamal M F Itani; Margaret E Plomondon; Laura K Altom; William G Henderson; Christopher L Bryson; Thomas M Maddox
Journal:  J Am Coll Surg       Date:  2012-02-16       Impact factor: 6.113

2.  Coronary-artery revascularization before elective major vascular surgery.

Authors:  Edward O McFalls; Herbert B Ward; Thomas E Moritz; Steven Goldman; William C Krupski; Fred Littooy; Gordon Pierpont; Steve Santilli; Joseph Rapp; Brack Hattler; Kendrick Shunk; Connie Jaenicke; Lizy Thottapurathu; Nancy Ellis; Domenic J Reda; William G Henderson
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

3.  Characterization of post-operative risk associated with prior drug-eluting stent use.

Authors:  Saif Anwaruddin; Arman T Askari; Hammad Saudye; Lilian Batizy; Penny L Houghtaling; Mohammad Alamoudi; Michael Militello; Kamran Muhammad; Samir Kapadia; Stephen G Ellis
Journal:  JACC Cardiovasc Interv       Date:  2009-06       Impact factor: 11.195

4.  Fourth Universal Definition of Myocardial Infarction (2018).

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Bernard R Chaitman; Jeroen J Bax; David A Morrow; Harvey D White
Journal:  Circulation       Date:  2018-11-13       Impact factor: 29.690

5.  Hospital Readmission After Perioperative Acute Myocardial Infarction Associated With Noncardiac Surgery.

Authors:  Nathaniel R Smilowitz; Joshua A Beckman; Scott E Sherman; Jeffrey S Berger
Journal:  Circulation       Date:  2018-03-10       Impact factor: 29.690

6.  Incomplete Revascularization Is Associated With an Increased Risk for Major Adverse Cardiovascular Events Among Patients Undergoing Noncardiac Surgery.

Authors:  Ehrin J Armstrong; Laura A Graham; Stephen W Waldo; Javier A Valle; Thomas M Maddox; Mary T Hawn
Journal:  JACC Cardiovasc Interv       Date:  2017-02-01       Impact factor: 11.195

Review 7.  Perioperative Management to Reduce Cardiovascular Events.

Authors:  Nathaniel R Smilowitz; Jeffrey S Berger
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690

8.  Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery.

Authors:  Giora Landesberg; Vadim Shatz; Inna Akopnik; Yehuda G Wolf; Michael Mayer; Yacov Berlatzky; Charles Weissman; Morris Mosseri
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

9.  Perioperative Cardiovascular Risk of Prior Coronary Stent Implantation Among Patients Undergoing Noncardiac Surgery.

Authors:  Karim D Mahmoud; Saurabh Sanon; Elizabeth B Habermann; Ryan J Lennon; Kristine M Thomsen; Douglas L Wood; Felix Zijlstra; Robert L Frye; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2016-03-08       Impact factor: 24.094

10.  Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies.

Authors:  Roberta Rossini; Giuseppe Musumeci; Luigi Oltrona Visconti; Ezio Bramucci; Battistina Castiglioni; Stefano De Servi; Corrado Lettieri; Maddalena Lettino; Emanuela Piccaluga; Stefano Savonitto; Daniela Trabattoni; Davide Capodanno; Francesca Buffoli; Alessandro Parolari; Gianlorenzo Dionigi; Luigi Boni; Federico Biglioli; Luigi Valdatta; Andrea Droghetti; Antonio Bozzani; Carlo Setacci; Paolo Ravelli; Claudio Crescini; Giovanni Staurenghi; Pietro Scarone; Luca Francetti; Fabio D'Angelo; Franco Gadda; Andrea Comel; Luca Salvi; Luca Lorini; Massimo Antonelli; Francesco Bovenzi; Alberto Cremonesi; Dominick J Angiolillo; Giulio Guagliumi
Journal:  EuroIntervention       Date:  2014-05       Impact factor: 6.534

View more
  1 in total

1.  Relation of Previous Coronary Artery Bypass Grafting and/or Percutaneous Coronary Intervention to Perioperative Cardiovascular Outcomes in Patients Who Underwent Noncardiac Surgery.

Authors:  Nina Singh; Jeffrey S Berger; Nathaniel R Smilowitz
Journal:  Am J Cardiol       Date:  2022-02-19       Impact factor: 2.778

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.